Evidence map›Paper›PMID 42798868›Full record

ArticleJCEM case reports2026

Episodic hypercortisolemia-mediated periods of worsening hyperglycemia in cyclic Cushing syndrome.

Mercedes Martinez-Gil, Shadee Aghel, Julie Nguyen, Tshibambe N Tshimbombu, Kevin C J Yuen

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mercedes Martinez-GilDepartment of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.ORCID https://orcid.org/0000-0002-4022-1049
Shadee AghelCreighton University School of Medicine, Phoenix, AZ 85012, USA.ORCID https://orcid.org/0009-0005-7773-3565
Julie NguyenDepartment of Endocrinology, University of Arizona College of Medicine, Phoenix, AZ 85004, USA.ORCID https://orcid.org/0000-0001-6520-2832
Tshibambe N TshimbombuDepartment of Neurological Sciences, Larner College of Medicine at the University of Vermont, Burlington, VT 05403, USA.ORCID https://orcid.org/0000-0001-7319-3980
Kevin C J YuenBarrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton University School of Medicine, Phoenix, AZ 85013, USA.ORCID https://orcid.org/0000-0002-8169-2728

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic Cushing syndrome (CCS) is a rare subtype of Cushing syndrome (CS) characterized by hypercortisolism alternating with periods of physiologic or even low cortisol secretion. Most patients with CCS present with clinical signs of CS; however, in some patients, signs of hypercortisolism may be subtle or even absent. The fluctuating clinical picture and discrepant biochemical findings make CCS difficult to diagnose. We describe a case of a 70-year-old man with well-controlled type 2 diabetes mellitus who experienced recurrent, spontaneous hypercortisolemic episodes resulting in worsening and difficult-to-control hyperglycemia, followed by eucortisolemic phases during which his glycemic control rapidly returned to baseline. Further biochemical evaluation revealed intermittent hypercortisolemia without a clearly identifiable source of an adrenocorticotropic hormone secreting lesion. Data from his continuous glucose monitoring system (CGMS) proved pivotal in detecting the hypercortisolemic phases and tailoring management. After declining bilateral adrenalectomy and opting for a block-and-replace regimen with osilodrostat and hydrocortisone, he was able to anticipate and initiate this treatment based on his CGMS readings, facilitating improved glycemic control during these periods. This case highlights the diagnostic complexity of CCS and the utility of CGMS as both a monitoring tool and treatment guide for CCS in patients with concurrent type 2 diabetes mellitus.

Indexed as

block-and-replace therapycyclic Cushing syndromehyperglycemiaosilodrostat

Identifiers

PMID42798868
PMCPMC13613223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.